Synapse - Elizabeth Chamberlain

Elizabeth Chamberlain

Research Focus

Former Employee. Research and Technology Management; Senior Manager, Study Start Up (Sr PAM)

Recent additions – View all

KIR3DL1 allelic polymorphism and HLA-B epitopes modulate response to anti-GD2 monoclonal antibody in patients with neuroblastoma
Journal Article

Forlenza, C. J.; Boudreau, J. E.; Zheng, J.; Le Luduec, J. B.; Chamberlain, E.; Heller, G.; Cheung, N. K. V.; Hsu, K. C.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save
Relapse in patients with high-risk neuroblastoma after treatment with 3F8+GM-CSF+CIS-retinoic acid in first complete/very good partial remission: Patterns, management and long-term outcome
Meeting Abstract

Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Chamberlain, E.; Wolden, S.; Laquaglia, M.; Cheung, N. K. V.
Pediatric Blood and Cancer (2015)

Fulltext@MSK | Save
Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
International Journal of Cancer (2014)

Fulltext@MSK | Save

Co-authors at MSK

5

Cheung
4

Modak
3

Kramer
3

Kushner
2

Cheung
2

Heller
2

Hsu
2

Le Luduec
2

Ostrovnaya
2

Zheng
1

Basu
1

Boudreau
1

Chapman
1

Dupont
1

Forlenza
1

Gallagher
1

Grinman
1

Kuk
1

La Quaglia
1

Pandit-...
1

Roberts
1

Tarek
1

Venstrom
1

Wolden
1

Wu

Types of Work

Publications